Role of HPV testing in secondary and primary screening of cervical neoplasia

J Monsonego - Journal of Lower Genital Tract Disease, 2000 - journals.lww.com
Objective. To evaluate the performance of HPV testing in identifying cervical neoplasia.
Materials and Methods. Minor cytologic atypia of the uterine cervix, particularly atypical …

[PDF][PDF] The triage of squamous cell abnormalities of cervical cytology by human papilloma virus screening

AA Ozsaran, Y Dikmen… - Eur. J. Gynaec. Oncol.-ıssN, 2003 - article.imrpress.com
Objective: The aim of the study was to determine the presence of human papilloma virus
(HPV) infection in cervical swabs by the use of the Digene” Hybrid Capture assay in a cohort …

Relevance of the Pap test: a report of HPV-DNA test-negative high-grade squamous intraepithelial lesions of the female lower genital tract

Y Hui, K Hansen, J Murthy, D Chau, CJ Sung… - Acta Cytologica, 2016 - karger.com
Objective: A vast majority of cervicovaginal intraepithelial lesions are caused by high-risk
human papillomaviruses (HPVs). The Pap test has been the sole method used for the …

Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial

A Lytwyn, JW Sellors, JB Mahony, D Daya… - Cmaj, 2000 - Can Med Assoc
Background: Results of cervical cytology screening showing atypical squamous cells of
undetermined significance (ASCUS) or low-grade squamous intraepithelial lesions (LSIL) …

[HTML][HTML] Clinical significance of HPV-DNA testing for precancerous cervical lesions

M Moarcăs, IC Georgescu, E Brătilă… - Journal of Medicine …, 2014 - ncbi.nlm.nih.gov
Cervical screening by using cytology was proven efficient in reducing the mortality
secondary to cervical cancer, but this method has limitations. High risk HPV infection is …

Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results

MM Manos, WK Kinney, LB Hurley, ME Sherman… - Jama, 1999 - jamanetwork.com
ContextA Papanicolaou (Pap) test result of atypical squamous cells of undetermined
significance (ASCUS) presents a clinical challenge. Only 5% to 10% of women with ASCUS …

Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial.

LA Koutsky - 2000 - cabidigitallibrary.org
Human papillomavirus (HPV) infections appear to be central to the development of cervical
cancer. This study addresses the question of whether testing women who have low-grade …

Combining human papillomavirus testing or cervicography with cytology to detect cervical neoplasia

M Howard, JW Sellors, A Lytwyn… - … of pathology & …, 2004 - meridian.allenpress.com
Context.—Cervicography and oncogenic human papillomavirus (HPV) testing have been
proposed for improving the accuracy of cervical cancer screening. Objective.—To examine …

Can human papillomavirus DNA testing substitute for cytology in the detection of high-grade cervical lesions?

IS Hong - Archives of pathology & laboratory medicine, 2005 - meridian.allenpress.com
Use of the Pap test plus concurrent HPV DNA assay of residual liquidbased samples is a
reproducible, accurate, and cost-effective follow-up method for women with ASCUS and …

HPV testing in patients with low grade cervical cytological abnormalities: a follow up study.

CS Herrington, MF Evans, FM Charnock… - Journal of clinical …, 1996 - jcp.bmj.com
AIM: To assess the diagnostic performance of human papillomavirus (HPV) analysis in
predicting cervical intraepithelial neoplasia (CIN) grades 2 and 3 in patients with persistent …